Involvement of phosphatidylinositol 3-kinase/Akt on basic fibroblast growth factor-induced glial cell line-derived neurotrophic factor release from rat glioma cells

Brain Research

Volumn 1463, Issue , 2012, Pages 21-29

  Tanabe, Kumiko ^a   Matsushima Nishiwaki, Rie ^a   Iida, Miki ^a   Kozawa, Osamu ^a   Iida, Hiroki ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Akt; Astrocyte; Basic fibroblast growth factor; Glial cell line derived neurotrophic factor; Phosphatidylinositol 3 kinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; FIBROBLAST GROWTH FACTOR 2; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; NEUROTROPHIC FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; WORTMANNIN;

ANIMAL CELL; ARTICLE; ATTENUATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; GLIA CELL; GLIOMA CELL; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; RAT; RECEPTOR DOWN REGULATION;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CHROMONES; FIBROBLAST GROWTH FACTOR 2; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIOMA; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MORPHOLINES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; UP-REGULATION;

RATTUS;

EID: 84861889130     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.04.057     Document Type: Article

References (29)

1. Alessi, D.R., Cuenda, A., Cohen, P., Dudley, D.T., Saltiel, A.R., 1995. PD98059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270, 27489-27494.
2. Arcaro, A., Wymann, M.P., 1993. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem. J. 296, 297-301. (Pubitemid 23350826)
3. Bennett, B.L., Sasaki, D.T., Murray, B.W., O'Leary, E.C., Sakata, S.T., Xu, W., Leisten, J.C., Motiwala, A., Pierce, S., Satoh, Y., Bhagwat, S.S., Manning, A.M., Anderson, D.W., 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U. S. A. 98, 13681-13686. (Pubitemid 33115958)
4. Brazil, D.P., Hemmings, B.A., 2001. Ten years of protein kinase B signaling: a hard Akt to follow. Trends Biochem. Sci. 26, 657-664. (Pubitemid 33042488)
5. Brazil, D.P., Yang, Z.-Z., Hemmings, B.A., 2004. Advances in protein kinase B signaling: AKTion on multiple fronts. Trends Biochem. Sci. 29, 233-242. (Pubitemid 38591317)
6. Burke, R.E., 2007. Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: two approaches with therapeutic potential in the treatment of neurodegenerative disease. Pharmacol. Ther. 114, 261-277. (Pubitemid 46844843)
7. Cantley, L.C., 2002. The phosphoinositide 3-kinase pathway. Science 296, 1655-2657.
8. Cuenda, A., Rouse, J., Doza, Y.N., Meier, R., Cohen, P., Gallagher, T.F., Young, P.R., Lee, J.C., 1995. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364, 229-233.
9. Dailey, L., Ambrosetti, D., Mansukhani, A., Basilico, C., 2005. Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev. 16, 233-247. (Pubitemid 40616120)
10. Eswarakumar, V.P., Lax, I., Schlessinger, J., 2005. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 16, 139-149. (Pubitemid 40616112)
11. Gao, Q., Li, Y., Chopp, M., 2005. Bone marrow stromal cells increase astrocyte survival via upregulation of phosphoinositide 3-kinase/threonine protein kinase and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathways and stimulate astrocyte trophic factor gene expression after anaerobic insult. Neuroscience 136, 123-134. (Pubitemid 41483841)
12. Hung, S.-Y., Liou, H.-C., Fu,W.-M., 2010. The mechanism of heme oxygenase-1 action involved in the enhancement of neurotrophic factor expression. Neuropharmacology 58, 321-329.
13. Katoh, M., Katoh, M., 2006. Cross-talk of WNT and FGF signaling pathways at GSK3β-catenin and SNAIL signaling cascades. Cancer Biol. Ther. 5, 1059-1064. (Pubitemid 44772212)
14. Kyriakis, J.M., Avruch, J., 2001. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81, 807-869. (Pubitemid 32267078)
15. Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
16. Lenhard, T., Schober, A., Suter-Crazzolara, C., Unsicker, K., 2002. Fibroblast growth factor-2 requires glial-cell-line derived neurotrophic factor for exerting its neuroprotective actions on glutamate-lesioned hippocampal neurons. Mol. Cell. Neurosci. 20, 181-197. (Pubitemid 34762130)
17. Mattson, M.P., Kumar, K.N., Wang, H., Cheng, B., Michaelis, E.K., 1993. Basic FGF regulates the expression of a functional 71 kDa NMDA receptor protein thatmediates calcium influx and neurotoxicity in hippocampal neurons. J. Neurosci. 13, 4575-4588. (Pubitemid 23326331)
18. Merighi, S., Benini, A., Mirandola, P., Gessi, S., Varani, K., Leung, E., MacLennan, S., Baraldi, P.G., Borea, P.A., 2006. Modulation of the Akt/Ras/Raf/MEK/ERK pathway by A3 adenosine receptor. Purinergic Signal. 2, 627-632. (Pubitemid 44848674)
19. Reuss, B., von Bohlen und Halbach, O., 2003. Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res. 313, 139-157.
20. Saavedra, A., Baltazar, G., Duarte, E.P., 2008. Driving GDNF expression: the green and the red traffic lights. Prog. Neurobiol. 86, 186-215.
21. Shimizu, T., Kagawa, T., Inoue, T., Nonaka, A., Takada, S., Aburatani, H., Taga, T., 2008. Stabilized β-catenin functions through TCF/LEF proteins and the notch/RBP-J complex to promote proliferation and suppress differentiation of neural precursor cells. Mol. Cell. Biol. 28, 7427-7441.
22. Shin, S.Y., Song, H., Kim, C.G., Choi, Y.-K., Lee, K.S., Lee, S.-J., Lee, H.-J., Lim, Y., Lee, Y.H., 2009. Egr-1 is necessary for fibroblast growth factor-2-induced transcriptional activation of the glial cell line-derived neurotrophic factor in murine astrocyte. J. Biol. Chem. 284, 30583-30593.
23. Suter-Crazzolara, C., Unsicker, K., 1996. GDNF mRNA levels are induced by FGF-2 in rat C6 glioblastoma cells. Mol. Brain Res. 41, 175-182. (Pubitemid 26288159)
24. Tanabe, K., Nishimura, K., Dohi, S., Kozawa, O., 2009. Mechanisms of interleukin-1β-induced GDNF release from rat glioma cells. Brain Res. 1274, 11-20.
25. Verity, A.N., Wyatt, T.L., Hajos, B., Eglan, R.M., Baecker, P.A., Johnson, R.M., 1998. Regulation of glial cell line-derived neurotrophic factor release from rat C6 glioblastoma cells. J. Neurochem. 70, 531-539. (Pubitemid 28079342)
26. Vlahos, C.J., Matter, W.F., Hui, K.Y., Brown, R.F., 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran-4-one (LY294002). J. Biol. Chem. 269, 5721-5728.
27. Wu, D., 2005. Neuroprotection in experimental stroke with targeted neurotrophins. NeuroRx. 2, 120-128. (Pubitemid 40128032)
28. Yun, Y.-R., Won, J.E., Jeon, E., Lee, S., Kang, W., Jo, H., Jang, J.-H., Shin, U.S., Kim, H.-W., 2010. Fibroblast growth factors: biology, function, and application for tissue regeneration. J. Tissue Eng. 7, 218142.
29. Zhao, H., Sapolsky, R.M., Steinberg, G.K., 2006. Phosphoinositide-3- kinase/Akt survival signal pathways are implicated in neuronal survival after stroke. Mol. Neurobiol. 34, 249-277.